Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy.

IF 5.4 3区 材料科学 Q2 CHEMISTRY, PHYSICAL ACS Applied Energy Materials Pub Date : 2024-03-01 Epub Date: 2023-09-20 DOI:10.1007/s10741-023-10340-3
Frank L Dini, Erberto Carluccio, Stefano Ghio, Nicola Riccardo Pugliese, Giangiacomo Galeotti, Michele Correale, Matteo Beltrami, Carlo Gabriele Tocchetti, Valentina Mercurio, Stefania Paolillo, Alberto Palazzuoli
{"title":"Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy.","authors":"Frank L Dini, Erberto Carluccio, Stefano Ghio, Nicola Riccardo Pugliese, Giangiacomo Galeotti, Michele Correale, Matteo Beltrami, Carlo Gabriele Tocchetti, Valentina Mercurio, Stefania Paolillo, Alberto Palazzuoli","doi":"10.1007/s10741-023-10340-3","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure (HF) is a progressive condition with a clinical picture resulting from reduced cardiac output (CO) and/or elevated left ventricular (LV) filling pressures (LVFP). The original Diamond-Forrester classification, based on haemodynamic data reflecting CO and pulmonary congestion, was introduced to grade severity, manage, and risk stratify advanced HF patients, providing evidence that survival progressively worsened for those classified as warm/dry, cold/dry, warm/wet, and cold/wet. Invasive haemodynamic evaluation in critically ill patients has been replaced by non-invasive haemodynamic phenotype profiling using echocardiography. Decreased CO is not infrequent among ambulatory HF patients with reduced ejection fraction, ranging from 23 to 45%. The Diamond-Forrester classification may be used in combination with the evaluation of natriuretic peptides (NPs) in ambulatory HF patients to pursue the goal of early identification of those at high risk of adverse events and personalise therapy to antagonise neurohormonal systems, reduce congestion, and preserve tissue/renal perfusion. The most benefit of the Guideline-directed medical treatment is to be expected in stable patients with the warm/dry profile, who more often respond with LV reverse remodelling, while more selective individualised treatments guided by echocardiography and NPs are necessary for patients with persisting congestion and/or tissue/renal hypoperfusion (cold/dry, warm/wet, and cold/wet phenotypes) to achieve stabilization and to avoid further neurohormonal activation, as a result of inappropriate use of vasodilating or negative chronotropic drugs, thus pursuing the therapeutic objectives. Therefore, tracking the haemodynamic status over time by clinical, imaging, and laboratory indicators helps implement therapy by individualising drug regimens and interventions according to patients' phenotypes even in an ambulatory setting.</p>","PeriodicalId":4,"journal":{"name":"ACS Applied Energy Materials","volume":null,"pages":null},"PeriodicalIF":5.4000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Energy Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10741-023-10340-3","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Heart failure (HF) is a progressive condition with a clinical picture resulting from reduced cardiac output (CO) and/or elevated left ventricular (LV) filling pressures (LVFP). The original Diamond-Forrester classification, based on haemodynamic data reflecting CO and pulmonary congestion, was introduced to grade severity, manage, and risk stratify advanced HF patients, providing evidence that survival progressively worsened for those classified as warm/dry, cold/dry, warm/wet, and cold/wet. Invasive haemodynamic evaluation in critically ill patients has been replaced by non-invasive haemodynamic phenotype profiling using echocardiography. Decreased CO is not infrequent among ambulatory HF patients with reduced ejection fraction, ranging from 23 to 45%. The Diamond-Forrester classification may be used in combination with the evaluation of natriuretic peptides (NPs) in ambulatory HF patients to pursue the goal of early identification of those at high risk of adverse events and personalise therapy to antagonise neurohormonal systems, reduce congestion, and preserve tissue/renal perfusion. The most benefit of the Guideline-directed medical treatment is to be expected in stable patients with the warm/dry profile, who more often respond with LV reverse remodelling, while more selective individualised treatments guided by echocardiography and NPs are necessary for patients with persisting congestion and/or tissue/renal hypoperfusion (cold/dry, warm/wet, and cold/wet phenotypes) to achieve stabilization and to avoid further neurohormonal activation, as a result of inappropriate use of vasodilating or negative chronotropic drugs, thus pursuing the therapeutic objectives. Therefore, tracking the haemodynamic status over time by clinical, imaging, and laboratory indicators helps implement therapy by individualising drug regimens and interventions according to patients' phenotypes even in an ambulatory setting.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用超声心动图和利钠肽对患者表型进行分析,以个性化心力衰竭治疗。
心力衰竭(HF)是一种渐进性疾病,其临床表现是由心输出量(CO)降低和/或左心室(LV)充盈压(LVFP)升高引起的。最初的Diamond Forrester分类基于反映CO和肺充血的血液动力学数据,用于对晚期HF患者的严重程度进行分级、管理和风险分层,提供了证据表明,被分类为暖/干、冷/干、暖/湿和冷/湿的患者的生存率逐渐恶化。危重患者的有创血流动力学评估已被使用超声心动图的无创血流动力学表型分析所取代。在射血分数降低(23%至45%)的门诊HF患者中,CO降低并不罕见。Diamond Forrester分类可与评估流动性HF患者的钠尿肽(NP)结合使用,以追求早期识别不良事件高危人群的目标,并进行个性化治疗,对抗神经激素系统,减少充血,保护组织/肾脏灌注。指南指导的医疗治疗的最大益处是预期在具有温暖/干燥特征的稳定患者中,他们更经常对左心室反向重塑做出反应,而对于持续充血和/或组织/肾脏灌注不足(冷/干、温/湿和冷/湿表型)的患者,超声心动图和NP指导下的更具选择性的个性化治疗是必要的,以实现稳定并避免由于不适当使用血管舒张或负性变时药物而导致的进一步神经激素激活,从而达到治疗目的。因此,通过临床、影像学和实验室指标跟踪一段时间内的血液动力学状态,有助于根据患者的表型,甚至在门诊环境中,通过个性化的药物方案和干预措施来实施治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Energy Materials
ACS Applied Energy Materials Materials Science-Materials Chemistry
CiteScore
10.30
自引率
6.20%
发文量
1368
期刊介绍: ACS Applied Energy Materials is an interdisciplinary journal publishing original research covering all aspects of materials, engineering, chemistry, physics and biology relevant to energy conversion and storage. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrate knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important energy applications.
期刊最新文献
Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences Correction to: Code-ICH: A New Paradigm for Emergency Interventionn. Digital Twin Methodology in Food Processing: Basic Concepts and Applications. To What Extent are Food, Culture, Economics and the Natural Environment Reflected in the Language of the Australian and Brazilian Food-based Dietary Guidelines? Ultra-processed Food Intake During Pregnancy and its Impact on Maternal Diet Quality and Weight Change: A Systematic Review of Observational Studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1